Picture of Fagron NV logo

FAGR Fagron NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Fagron rises on 'solid' FY25 results

** * Shares in Fagron FAGRO.BR rise 4.9% after the Belgian pharmaceuticals producer reported better-than-expected FY results

** KBC securities says Fagron delivered a solid FY25 performance, with revenue coming in 1% above consensus expectations, mainly supported by better-than-expected growth

in North America

** The broker adds that the FY REBITDA reached €193m, coming in 1.6% above CSS expectations, as all regions reported slightly higher margins than anticipated

** "This is a good set of results, underpinned by solid, robust organic growth and disciplined execution" - KBC

** Share on track for a best day since April 2025, when it closed 5.9% higher

** Up to the previous session's close, shares were up 1.4%​ YTD

(Reporting by Marianna Ciabach-Malinowska)

((Marianna.ciabach@tr.com))

Recent news on Fagron NV

See all news